Story thread · 22 reports / 12 sources

Novo Nordisk faces a rough patch

semafor.com · 5d

Novo Nordisk faces a rough patch

How the coverage leans

Across 12 sources · syndicated copies counted once

Novo’s shares have fallen 15% this year, tumbling further this week after guidance missed analysts’ targets.

First report: Allison Transmission raises sales outlook, but higher costs blunt stock gains seekingalpha.com, 8d

The coverage

  1. ConocoPhillips Q2 2026 slides: earnings surge on higher prices

    investing.com · 5d

  2. Lilly widens GLP-1 lead over Novo despite Wegovy pill gains

    beckershospitalreview.com · 5d

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.